2024

Smith, C. D.L., McMahon, A. D. , Purkayastha, M., Creaney, G. , Clements, K., Inman, G. J. , Bhatti, L. A., Douglas, C. M., Paterson, C. and Conway, D. I. (2024) Head and neck cancer incidence is rising but the sociodemographic profile is unchanging: a population epidemiological study (2001-2020). BJC Reports, 2, 71. (doi: 10.1038/s44276-024-00089-z) (PMID:39301277)

Clements, K., Thapa, A., Cowell, A., Conway, D. , Douglas, C. M. and Paterson, C. (2024) Impact of the COVID-19 pandemic on stage and incidence of head and neck cancer: a rapid review and meta-analysis. Clinical Otolaryngology, 49(4), pp. 363-375. (doi: 10.1111/coa.14152) (PMID:38514776)

Thapa, A. et al. (2024) The UK Divide: Does having a Pembrolizumab-Chemotherapy option in head and neck cancer matter? Real-world experience of first-line palliative pembrolizumab monotherapy and pembrolizumab-chemotherapy combination in Scotland. Clinical Oncology, 36(5), pp. 287-299. (doi: 10.1016/j.clon.2024.02.004) (PMID:38395634)

2023

Clements, K., Cowell, A., White, G., Flynn, W., Conway, D. I. , Douglas, C. M. and Paterson, C. (2023) The COVID-19 pandemic has not changed stage at presentation nor treatment patterns of head and neck cancer: a retrospective cohort study. Clinical Otolaryngology, 48(4), pp. 587-594. (doi: 10.1111/coa.14048) (PMID:36929626)

Hay, L. K., McLoone, P. , Borgaonkar, S., Schipani, S., Wilson, C., Grose, D., James, A. , Lamb, C. and Paterson, C. (2023) Can elderly patients be safely selected for head and neck radiotherapy without formal geriatric or frailty assessment: a retrospective cohort study. Clinical Otolaryngology, 48(2), pp. 240-244. (doi: 10.1111/coa.14005) (PMID:36366954)

Poon, W.-Y., Paterson, C., McLoone, P. , Grose, D., Schipani, S., Lamb, C., James, A. and Wilson, C. (2023) Survival outcomes in hypopharyngeal cancer in the West of Scotland Cancer Network. Clinical Otolaryngology, 48(2), pp. 235-239. (doi: 10.1111/coa.14003) (PMID:36344424)

2022

Creaney, G. , McMahon, A. D. , Ross, A. J. , Bhatti, L. A., Paterson, C. and Conway, D. I. (2022) Head and neck cancer in the UK: what was the stage before COVID-19? UK cancer registries analysis (2011-2018). British Dental Journal, 233(9), pp. 787-793. (doi: 10.1038/s41415-022-5151-4) (PMID:36369569) (PMCID:PMC9650177)

Zhou, S. et al. (2022) Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection. Oral Oncology, 128, 105870. (doi: 10.1016/j.oraloncology.2022.105870) (PMID:35447564)

Grocutt, L., Paterson, C. and Valentine, R. M. (2022) Adaptive dose escalated radiotherapy in oropharyngeal cancers: a treatment planning feasibility study. Radiation Oncology, 17, 24. (doi: 10.1186/s13014-022-01991-x) (PMID:35123516) (PMCID:PMC8817487)

2020

Poon, W.-Y. et al. (2020) Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck-involved neck only versus mucosal irradiation. Clinical Otolaryngology, 45(6), pp. 847-852. (doi: 10.1111/coa.13593) (PMID:32501648)

Hay, L. K. et al. (2020) Analysis of dose using CBCT and synthetic CT during head and neck radiotherapy: A single centre feasibility study. Technical Innovations and Patient Support in Radiation Oncology, 14, pp. 21-29. (doi: 10.1016/j.tipsro.2020.02.004) (PMID:32226833) (PMCID:PMC7093804)

2019

Paterson, C. et al. (2019) Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck. British Journal of Oral and Maxillofacial Surgery, 57(10), pp. 1119-1125. (doi: 10.1016/j.bjoms.2019.10.300) (PMID:31672256)

Articles

Smith, C. D.L., McMahon, A. D. , Purkayastha, M., Creaney, G. , Clements, K., Inman, G. J. , Bhatti, L. A., Douglas, C. M., Paterson, C. and Conway, D. I. (2024) Head and neck cancer incidence is rising but the sociodemographic profile is unchanging: a population epidemiological study (2001-2020). BJC Reports, 2, 71. (doi: 10.1038/s44276-024-00089-z) (PMID:39301277)

Clements, K., Thapa, A., Cowell, A., Conway, D. , Douglas, C. M. and Paterson, C. (2024) Impact of the COVID-19 pandemic on stage and incidence of head and neck cancer: a rapid review and meta-analysis. Clinical Otolaryngology, 49(4), pp. 363-375. (doi: 10.1111/coa.14152) (PMID:38514776)

Thapa, A. et al. (2024) The UK Divide: Does having a Pembrolizumab-Chemotherapy option in head and neck cancer matter? Real-world experience of first-line palliative pembrolizumab monotherapy and pembrolizumab-chemotherapy combination in Scotland. Clinical Oncology, 36(5), pp. 287-299. (doi: 10.1016/j.clon.2024.02.004) (PMID:38395634)

Clements, K., Cowell, A., White, G., Flynn, W., Conway, D. I. , Douglas, C. M. and Paterson, C. (2023) The COVID-19 pandemic has not changed stage at presentation nor treatment patterns of head and neck cancer: a retrospective cohort study. Clinical Otolaryngology, 48(4), pp. 587-594. (doi: 10.1111/coa.14048) (PMID:36929626)

Hay, L. K., McLoone, P. , Borgaonkar, S., Schipani, S., Wilson, C., Grose, D., James, A. , Lamb, C. and Paterson, C. (2023) Can elderly patients be safely selected for head and neck radiotherapy without formal geriatric or frailty assessment: a retrospective cohort study. Clinical Otolaryngology, 48(2), pp. 240-244. (doi: 10.1111/coa.14005) (PMID:36366954)

Poon, W.-Y., Paterson, C., McLoone, P. , Grose, D., Schipani, S., Lamb, C., James, A. and Wilson, C. (2023) Survival outcomes in hypopharyngeal cancer in the West of Scotland Cancer Network. Clinical Otolaryngology, 48(2), pp. 235-239. (doi: 10.1111/coa.14003) (PMID:36344424)

Creaney, G. , McMahon, A. D. , Ross, A. J. , Bhatti, L. A., Paterson, C. and Conway, D. I. (2022) Head and neck cancer in the UK: what was the stage before COVID-19? UK cancer registries analysis (2011-2018). British Dental Journal, 233(9), pp. 787-793. (doi: 10.1038/s41415-022-5151-4) (PMID:36369569) (PMCID:PMC9650177)

Zhou, S. et al. (2022) Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection. Oral Oncology, 128, 105870. (doi: 10.1016/j.oraloncology.2022.105870) (PMID:35447564)

Grocutt, L., Paterson, C. and Valentine, R. M. (2022) Adaptive dose escalated radiotherapy in oropharyngeal cancers: a treatment planning feasibility study. Radiation Oncology, 17, 24. (doi: 10.1186/s13014-022-01991-x) (PMID:35123516) (PMCID:PMC8817487)

Poon, W.-Y. et al. (2020) Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck-involved neck only versus mucosal irradiation. Clinical Otolaryngology, 45(6), pp. 847-852. (doi: 10.1111/coa.13593) (PMID:32501648)

Hay, L. K. et al. (2020) Analysis of dose using CBCT and synthetic CT during head and neck radiotherapy: A single centre feasibility study. Technical Innovations and Patient Support in Radiation Oncology, 14, pp. 21-29. (doi: 10.1016/j.tipsro.2020.02.004) (PMID:32226833) (PMCID:PMC7093804)

Paterson, C. et al. (2019) Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck. British Journal of Oral and Maxillofacial Surgery, 57(10), pp. 1119-1125. (doi: 10.1016/j.bjoms.2019.10.300) (PMID:31672256)